Elevra Lithium (ASX:ELV) shares have tumbled over 30% in a week, abruptly reversing a stellar year-long rally. With no clear catalyst, investors are left weighing whether the pullback presents a buying window or signals deeper concerns in the lithium sector.
Summit Therapeutics (SMMT) finds itself at a crossroads, with its stock down over 30% in the past year. Conflicting signals from valuation models paint a complex picture: is the biotech firm dramatically overvalued on traditional metrics, or deeply undervalued based on future cash flows?
A dominant institutional ownership stake in Resources Connection, Inc. (NASDAQ:RGP) underscores significant outside influence over the professional services firm's direction, while also highlighting concentrated risk and governance dynamics.
Brendan Banfield's murder trial reaches its climax Friday with closing arguments after he testified he shot a man he found stabbing his wife. Prosecutors allege an elaborate murder-for-hire plot, while the defense claims a tragic act of self-defense.
Tesla is discontinuing its flagship Model S sedan and Model X SUV, a strategic shift underscored by plummeting sales figures and Elon Musk's pivot toward robotics and autonomy.
Foreign women detained in Syria's Roj camp, linked to the Islamic State group, see a potential path to freedom following a government offensive that weakened their Kurdish guards. As political dynamics shift, their hopes for amnesty or repatriation collide with international reluctance and an uncertain future for the camps.
Deutsche Bank and its asset manager DWS are in preliminary talks to acquire a significant minority stake in Fosun-owned Frankfurter Leben, signaling a strategic reversal a decade after exiting the sector.
Marsh & McLennan's insurance brokerage giant Marsh reported a 4.2% rise in Q4 net income to $821 million, capping a year of robust growth and strategic brand realignment under the new 'Marsh Risk' banner.
Initial unemployment filings in Pennsylvania fell last week, contributing to a stable national picture, though sharp swings in other states highlight ongoing regional volatility.
Swiss watch and jewelry giant Swatch Group reported a steep decline in full-year profit and revenue, with pre-tax earnings nearly halved as consumer demand softened and operational costs climbed.
As Peloton Interactive prepares to report its Q2 fiscal 2026 results, investors are scrutinizing whether the fitness company's aggressive cost-cutting can finally fuel a sustainable turnaround, despite shares languishing 96% below their peak.
MarineMax's Q4 2025 results surpassed revenue forecasts, driven by robust premium boat sales, but profitability was hampered by industry-wide discounting and cautious consumer spending, leading to a wider-than-expected loss per share.
Tower Semiconductor (TSEM) has captured market attention with record revenue guidance and a major $650 million capacity expansion targeting silicon photonics and SiGe technologies. While shares have surged over 58% in 90 days, analysts are now debating whether the stock's premium valuation fully prices in future growth in AI, 5G, and data center markets.
A recent downgrade of Enbridge Inc. by J.P. Morgan analysts has intensified the debate over the pipeline giant's ability to balance future growth with its prized dividend stability, as macroeconomic headwinds pressure its core crude oil segment.
Levi Strauss & Co. (LEVI) posted stronger-than-expected full-year 2025 results, driven by organic growth and a strategic shift towards direct-to-consumer sales. Yet, with a muted stock performance year-to-date, investors are questioning if the iconic denim maker's transformation story is fully priced in.
After a volatile period that saw shares swing from steep declines to recent gains, investors are scrutinizing whether Weyerhaeuser's current price presents a buying opportunity. A deep dive into valuation metrics reveals a complex picture, with discounted cash flow and P/E ratio analyses telling conflicting stories.
The resignation of Prudential Financial's Japan life insurance CEO following a widespread employee misconduct scandal has triggered governance reviews and shaken investor confidence in one of the insurer's key international markets.
Axos Financial's recent acquisition of Verdant Commercial Capital and its deepening investment in artificial intelligence are translating into tangible financial gains, with robust loan growth and surging share prices highlighting the digital bank's evolving strategy.
A revised price target for Rithm Capital (NYSE: RITM) has prompted a fresh look at the mortgage REIT's prospects, with analysts weighing its strategic shifts against a complex macroeconomic backdrop.
Williams-Sonoma's shares have delivered impressive multi-year gains, but recent valuation metrics present a mixed picture. As the stock hovers around $205, we analyze whether the home goods retailer's price truly reflects its fundamentals or if investors are paying a premium for past performance.
